INmune Bio, Inc. – NASDAQ:INMB

Founder-led company

INmune Bio stock price today

$2.41
-2.24
-48.17%
Financial Health
0
1
2
3
4
5
6
7
8
9

INmune Bio stock price monthly change

-49.67%
month

INmune Bio stock price quarterly change

-49.67%
quarter

INmune Bio stock price yearly change

-58.56%
year

INmune Bio key metrics

Market Cap
98.88M
Enterprise value
101.79M
P/E
-5
EV/Sales
272.17
EV/EBITDA
-3.72
Price/Sales
370.68
Price/Book
2.30
PEG ratio
-0.31
EPS
-1.92
Revenue
131K
EBITDA
-34.33M
Income
-34.49M
Revenue Q/Q
-63.15%
Revenue Y/Y
-47.38%
Profit margin
-7299.2%
Oper. margin
-6938.77%
Gross margin
0%
EBIT margin
-6938.77%
EBITDA margin
-26209.92%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

INmune Bio stock price history

INmune Bio stock forecast

INmune Bio financial statements

INmune Bio, Inc. (NASDAQ:INMB): Profit margin
Jun 2023 46K -6.50M -14132.61%
Sep 2023 43K -8.56M -19913.95%
Dec 2023 28K -8.40M -30028.57%
Mar 2024 14K -11.02M -78750%
INmune Bio, Inc. (NASDAQ:INMB): Analyst Estimates
2025 29K -48.46M -167127.59%
2026 29.5K -49.05M -166274.58%
2027 82.70M 24.45M 29.57%
2028 146.16M 73.09M 50.01%
  • Analysts Price target

  • Financials & Ratios estimates

INmune Bio, Inc. (NASDAQ:INMB): Debt to assets
Jun 2023 69720000 19.06M 27.35%
Sep 2023 62698000 17.96M 28.65%
Dec 2023 57001000 18.86M 33.09%
Mar 2024 46833000 17.81M 38.03%
INmune Bio, Inc. (NASDAQ:INMB): Cash Flow
Jun 2023 -3.17M 0 0
Sep 2023 -4.26M -2.55M -1.72M
Dec 2023 -3.40M 2.55M -2.5M
Mar 2024 -7.47M 0 -2.5M

INmune Bio alternative data

INmune Bio, Inc. (NASDAQ:INMB): Employee count
Aug 2023 10
Sep 2023 10
Oct 2023 10
Nov 2023 10
Dec 2023 10
Jan 2024 10
Feb 2024 10
Mar 2024 10
Apr 2024 10
May 2024 11
Jun 2024 11
Jul 2024 11

INmune Bio other data

3.82% -5.34%
of INMB is owned by hedge funds
685.51K -959.49K
shares is hold by hedge funds

INmune Bio, Inc. (NASDAQ:INMB): Insider trades (number of shares)
Period Buy Sel
Nov 2023 7000 0
Apr 2024 160164 0
Jun 2024 5000 0
Sep 2024 56140 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MOSS DAVID J 10 percent owner, officer: Chie..
Common Stock 10,000 $5.29 $52,870
Purchase
TESI RAYMOND JOSEPH director, 10 perc.. Common Stock 15,380 $6.38 $98,048
Purchase
TESI RAYMOND JOSEPH director, 10 perc.. Common Stock Warrants (right to buy) 15,380 $6.4 $98,432
Purchase
MOSS DAVID J 10 percent owner, officer: Chie..
Common Stock 7,690 $6.38 $49,024
Purchase
MOSS DAVID J 10 percent owner, officer: Chie..
Common Stock Warrants (right to buy) 7,690 $6.4 $49,216
Purchase
JUDA SCOTT director
Common Stock 5,000 $7.27 $36,350
Purchase
MOSS DAVID J 10 percent owner, officer: CFO,..
Common Stock 18,028 $8.32 $149,993
Purchase
MOSS DAVID J 10 percent owner, officer: CFO,..
Common Stock Warrants (right to buy) 18,028 $9.15 $164,992
Purchase
TESI RAYMOND JOSEPH director, 10 perc.. Common Stock 18,028 $8.32 $149,993
Purchase
TESI RAYMOND JOSEPH director, 10 perc.. Common Stock Warrants (right to buy) 18,028 $9.15 $164,992
Patent
Application
Filling date: 13 May 2020 Issue date: 4 Aug 2022
Application
Filling date: 27 Sep 2018 Issue date: 17 Sep 2020
Insider Compensation
Mr. David J. Moss M.B.A. (1970) Chief Financial Officer, Treasurer & Sec.
$300,000
Dr. Raymond Joseph Tesi (1956) Co-Founder, Pres, Chief Executive Officer, Chief Medical Officer & Chairman $300,000
Dr. Mark William Lowdell BSc, MSc, Ph.D., FRCPath, MICR (1963) Chief Scientific Officer & Chief Manufacturing Officer
$138,200
Wednesday, 4 December 2024
globenewswire.com
Thursday, 31 October 2024
seekingalpha.com
globenewswire.com
Monday, 28 October 2024
globenewswire.com
Thursday, 24 October 2024
globenewswire.com
globenewswire.com
Friday, 11 October 2024
globenewswire.com
Monday, 30 September 2024
seekingalpha.com
Thursday, 26 September 2024
globenewswire.com
Tuesday, 17 September 2024
globenewswire.com
Friday, 13 September 2024
globenewswire.com
Tuesday, 3 September 2024
globenewswire.com
Thursday, 1 August 2024
seekingalpha.com
globenewswire.com
Monday, 29 July 2024
globenewswire.com
Thursday, 25 July 2024
globenewswire.com
Tuesday, 23 July 2024
globenewswire.com
Monday, 8 July 2024
seekingalpha.com
Friday, 5 July 2024
seekingalpha.com
Thursday, 30 May 2024
globenewswire.com
Saturday, 11 May 2024
Seeking Alpha
Monday, 22 April 2024
Seeking Alpha
Thursday, 28 March 2024
Seeking Alpha
Tuesday, 6 February 2024
GlobeNewsWire
Tuesday, 5 December 2023
Seeking Alpha
Sunday, 5 November 2023
InvestorPlace
Wednesday, 1 November 2023
Seeking Alpha
Monday, 31 July 2023
GlobeNewsWire
Friday, 2 June 2023
Proactive Investors
Wednesday, 24 May 2023
GlobeNewsWire
  • What's the price of INmune Bio stock today?

    One share of INmune Bio stock can currently be purchased for approximately $2.41.

  • When is INmune Bio's next earnings date?

    Unfortunately, INmune Bio's (INMB) next earnings date is currently unknown.

  • Does INmune Bio pay dividends?

    No, INmune Bio does not pay dividends.

  • How much money does INmune Bio make?

    INmune Bio has a market capitalization of 98.88M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 58.56% to 155K US dollars.

  • What is INmune Bio's stock symbol?

    INmune Bio, Inc. is traded on the NASDAQ under the ticker symbol "INMB".

  • What is INmune Bio's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of INmune Bio?

    Shares of INmune Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are INmune Bio's key executives?

    INmune Bio's management team includes the following people:

    • Mr. David J. Moss M.B.A. Chief Financial Officer, Treasurer & Sec.(age: 55, pay: $300,000)
    • Dr. Raymond Joseph Tesi Co-Founder, Pres, Chief Executive Officer, Chief Medical Officer & Chairman(age: 69, pay: $300,000)
    • Dr. Mark William Lowdell BSc, MSc, Ph.D., FRCPath, MICR Chief Scientific Officer & Chief Manufacturing Officer(age: 62, pay: $138,200)
  • Is INmune Bio founder-led company?

    Yes, INmune Bio is a company led by its founder Dr. Raymond Joseph Tesi.

  • How many employees does INmune Bio have?

    As Jul 2024, INmune Bio employs 11 workers, which is 10% more then previous quarter.

  • When INmune Bio went public?

    INmune Bio, Inc. is publicly traded company for more then 6 years since IPO on 4 Feb 2019.

  • What is INmune Bio's official website?

    The official website for INmune Bio is inmunebio.com.

  • Where are INmune Bio's headquarters?

    INmune Bio is headquartered at 225 NE Mizner Boulevard, Boca Raton, FL.

  • How can i contact INmune Bio?

    INmune Bio's mailing address is 225 NE Mizner Boulevard, Boca Raton, FL and company can be reached via phone at 858 964 3720.

INmune Bio company profile:

INmune Bio, Inc.

inmunebio.com
Exchange:

NASDAQ

Full time employees:

11

Industry:

Biotechnology

Sector:

Healthcare

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.

225 NE Mizner Boulevard
Boca Raton, FL 33432

CIK: 0001711754
ISIN: US45782T1051
CUSIP: 45782T105